For more than a decade, Carnegie Mellon neuroscientist Aryn Gittis has been unraveling the mystery of how the brain controls movement — research now pointing toward new treatments for Parkinson’s ...

Medtronic PLC investors again failed to adequately allege the device maker’s statements about its MiniMed insulin pumps constituted securities fraud, a federal court said. The latest version of the ...

The Department of Neurology and Neurological Sciences at Stanford University School of Medicine, together with multiple academic medical centers and one industry partner (Medtronic) across the US, ...

Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy for Parkinson’s disease.

Medtronic (NYSE: MDT) today announced study results backing its adaptive DBS algorithm for personalized therapy in Parkinson's.

"You can not stop and start R&D. You have to stay at it," former Medtronic CEO Bill George says in a Medical Design & Outsourcing interview.

WEDNESDAY, Sept. 3, 2025 (HealthDay News) -- Obtaining a prefrontal cortex (PFC) biopsy during deep brain stimulation (DBS) procedures is safe, according to a study published online Sept. 3 in ...

Tardive dyskinesia (TD) can be addressed by the right intervention even in severe, refractory cases. These cases, characterized by involuntary muscle movements, are most often caused by antipsychotics ...

In a deep red state, a public program focused on maternal and infant health has thrived for decades, and continues to win public support and federal dollars. Project WATCH -- which stands for Working ...

The Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) found that certain lifestyle interventions improved cognition in older ...

Deep brain stimulation (DBS) can be individually tweaked to improve walking in people with Parkinson’s disease Researchers developed a walking performance index based on patient’s gait and brain ...